EFSA has invited everybody to open discussion on the scientific requirements for health claims related to gut and immune function guidance. Submit your comments by 10 September 2014.
Last chance to leave an impact on EFSA’s Guidance on Statistical Reporting. You can submit your comments by 23 July 2014.
Vizera has a wealth of experience in clinical trials of pharmaceuticals and nutraceuticals and provides support with EFSA claim submission. We are highly skilled in several therapeutic areas, some of which include gastroenterology, cognitive functions, paediatric health, and the immune and cardiovascular systems.
Vizera’s project managers and experts work in a wide range of product development areas and are completely focused on achieving their goals regarding the development of pharmaceutical and nutraceutical products – from the initial concept right through to registration.
Before a product can be used, sold, supplied, advertised or stored, it must be approved for use. Vizera helps you make the right decisions on how to register your product in the EU in order to avoid incurring additional time and financial costs.